GPT Healthcare Limited operates as a prominent healthcare provider in Eastern India, boasting four medium-sized full-service hospitals located in West Bengal and Tripura. Together, these hospitals offer a total of 561 beds. Operating under the brand name ILS Hospitals, the company delivers comprehensive secondary and tertiary care services spanning across 35 specialties. These services encompass intensive care, neurology, nephrology (including kidney transplant), orthopedics and joint replacement, internal medicine and diabetology, neurosurgery, integrated diagnostic services, gynecology and obstetrics, laparoscopic and general surgery, gastroenterology, interventional cardiology, pediatrics, neonatology, and pharmacy services.
IPO Timeline Details:
GPT Healthcare IPO
Date
IPO Offer Start
22 Feb 2024
IPO Offer Ends
26 Feb 2024
Allotment Finalisation
27 Feb 2024
Refund Initialisation
28 Feb 2024
Share Transfer to Demat
28 Feb 2024
Listing of Shares
29 Feb 2024
Financial Performance Overview:
Year
Revenue
Total Assets
Profit
2021
243
317
21.09
2022
337
323
41.66
2023
361
327
39.01
All values are in Cr
Strengths and Risks: GPT Healthcare IPO
Strengths:
GPT Healthcare is recognized as one of the key regional corporate healthcare companies in Eastern India, boasting a significant number of beds and hospitals, as per a CRISIL report for Fiscal year 2023.
With 20 years of operational experience in the region, the company has established a strong presence and reputation.
The company offers a diversified service portfolio as a multispecialty healthcare platform, allowing for diversified revenue streams.
It provides advanced healthcare services in specialties like nephrology (including renal transplants) and diabetology, in addition to core medical and surgical services.
GPT Healthcare has demonstrated substantial growth by expanding its hospital bed capacity from eight beds in July 2000 to 561 beds by September 30, 2023.
The company has increased its medical professional staff significantly, from 945 in 2021 to 1312 as of Sep 30, 2023.
It has reported consistent operational revenues over the years, with revenues of Rs. 361.04 cr, Rs. 337.42 cr, and Rs. 242.75 cr for Fiscal Years 2023, 2022, and 2021 respectively.
Risks:
Approximately 70% of the company’s operational revenue is generated from hospitals located in West Bengal, exposing it to potential economic and political risks specific to the region.
Inclusion of a member of the Promoter Group, Ishwari Prasad Tantia, as a Wilful Defaulter by some financial institutions poses a risk to the company’s reputation and operations.
Involvement of the company, its Promoters, and Directors in legal proceedings may have adverse impacts on operations and financial stability.
The company has significant commitments and contingent liabilities, amounting to Rs. 1.8 cr as of September 2023, which may affect its financial condition.
Dependency on third-party suppliers and manufacturers for supplies and equipment exposes the company to the risk of disruptions in the supply chain, potentially impacting business operations and cash flows.
Application Details:
Apply as Regular: The price is ₹ 177–186. You can apply up to ₹2 Lakh
Apply as a high-net-worth individual: The price is ₹ 177–186. You can apply between ₹5 Lakh
Disclaimer
Stock Market investments are subject to market risks. All the information provided on our IPO Mentor Portal is for education purposes only. Kindly consult your Financial Advisor before taking any decision.
